Toshiba unveils wide-bore 3T MR scanner
Toshiba laid the groundwork for entering the 3T marketplace in the U.S. with the unveiling of its Vantage Titan 3T system at RSNA 2009. The work-in-progress, which is pending FDA clearance, leapfrogs earlier generations of 3T scanners with a 71-cm tapered aperture and Pianissimo noise reduction technology.
Toshiba laid the groundwork for entering the 3T marketplace in the U.S. with the unveiling of its Vantage Titan 3T system at RSNA 2009. The work-in-progress, which is pending FDA clearance, leapfrogs earlier generations of 3T scanners with a 71-cm tapered aperture and Pianissimo noise reduction technology.
The new wide-bore system incorporates the ability to perform contrast-free MR angiography exams, including Fresh Blood Imaging (FBI) for evaluating peripheral vascular diseases of the lower legs and extremities, Contrast-free Improved Angiography (CIA) for easier visualization of smaller vessels, Time-Spatial Labeling Inversion Pulse (Time-SLIP) for evaluating hemodynamic functional assessments and visualization of vascular structures, and Time and Space Angiography (TSA) to create noncontrast time-resolved imaging with high temporal resolution.
The 3T system utilizes Toshiba's Atlas coil technology integrated into the table to allow patients to be examined without having to be continually repositioned for different exams. The product is being designed with a new user interface called M-Power that promises to simplify training and operation.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
